Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Serán Bioscience

Explore full profile

Is committed to helping its clients develop successful drugs

Bend, United StatesFounded 2016Biotech & Life Sciences
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Serán Bioscience and the history behind them.

About Serán Bioscience

Serán Bioscience is a cutting-edge company specializing in pharmaceutical innovation. Operating as a Contract Development and Manufacturing Organization (CDMO), Serán Bioscience provides a range of services that support the development and manufacturing of drugs. The company focuses on advanced drug formulation techniques, including preformulation services, formulation development, dosage form development, spray drying, and particle engineering. Their expertise extends to cGMP (current Good Manufacturing Practice) manufacturing and analytical quality control, ensuring that their products meet the highest standards of quality and safety.

Serán Bioscience serves a diverse clientele, primarily pharmaceutical companies that require specialized drug development and manufacturing services. These clients range from small biotech startups to large pharmaceutical corporations. The company operates in the highly competitive pharmaceutical and biotechnology markets, where innovation and precision are crucial.

The business model of Serán Bioscience is service-based. They generate revenue by offering their specialized drug development and manufacturing services to pharmaceutical companies. Clients pay for the expertise, technology, and facilities that Serán provides, which allows them to develop and manufacture their drugs more efficiently and effectively. The company is known for its flexibility and dedication, which are highly valued by their clients. This flexibility allows them to tailor their services to meet the specific needs of each client, ensuring successful outcomes.

In summary, Serán Bioscience combines state-of-the-art technology with unparalleled scientific expertise to revolutionize drug development. Their commitment to innovation and rigorous thinking challenges assumptions and achieves successful outcomes for their clients.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Bend, United States
Sector
Biotech & Life Sciences

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States91.2%
🇦🇺 Australia7.4%
🇯🇵 Japan0.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Serán Bioscience on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Serán Bioscience on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.